Amylyx Pharmaceuticals Inc (AMLX)

[jmgreeny]

So price of Amlx 23-24 price target 50 by financial analyst. Steady slide lower to 18.

Any news on why

[conix]

Another viewpoint on the ALS drug

https://www.medpagetoday.com/opinion/second-opinions/101206?xid=nl_secondopinion_2022-10-16&eun=g350924d0r

[MiamiGent]

Ya Max, I see it kicking up it hoffs, want'n to go.
I have one share as a bookmark. Look'n to pounce on any dip
Have already banked nicely on this

https://stockcharts.com/h-sc/ui?s=AMLX

[Max77]

Notice the cup and handle formation- super bullish chart pattern

[MiamiGent]

.
AMLX Amylyx Pharmaceuticals Receives FDA Approval Of Relyvrio For Treatment Of Amyotrophic Lateral Sclerosis
By Benzinga — 4:38 PM ET 09/29/22

[MiamiGent]

AMLX The Motley Fool
Sun, September 25, 2022 at 9:23 AM

AMLX Three Motley Fool contributors have joined this roundtable to scour the market for some exciting initial public offerings (IPOs) in the healthcare field. Alex Carchidi (Amylyx Pharmaceuticals): Amylyx is worth owning because there's a solid chance it'll soon commercialize the first treatment for amyotrophic lateral sclerosis (ALS) that prolongs survival time while also slowing the disease's progression. Its medicine, AMX0035, has been approved for sale in Canada since late July, and regulators at the U.S. Food and Drug Administration will weigh in on the company's application for commercialization on Sept. 29.This biotech is ready for blastoff
It's also in the final stages of preparing to launch the drug in the European Union, pending the green light from regulators, which could come in the first half of 2023.

Since its IPO in early January of this year, its shares are up by nearly 61.6%, and it'll likely rise even higher. Right now, its revenue is negligible, as there hasn't been an earnings report since the approval of its drug in Canada. But next year, analysts estimate on average that it'll bring in around $174 million if AMX0035 launches in the U.S. as planned, and that'll mean the company's top revenue growth rate should accelerate dramatically.

NASDAQ: AMLX
Amylyx Pharmaceuticals, Inc.
Today's Change
(+3.23%) $0.91
Current Price
$29.09
KEY DATA POINTS
Market Cap
$2B
Day's Range
$27.95 - $29.45
52wk Range
$6.51 - $33.41
Volume
515,343
Avg Vol
1,572,472
Gross Margin
-20475.44%
Dividend Yield
N/A

Furthermore, there aren't any other ALS medicines, so Amylyx will have free rein of the global market, and that could power shareholder returns for years. And, as it already has its foot in the door thanks to its approval in Canada, it isn't as risky as other biotech stocks, though it's still not exactly a great pick for investors with a low risk tolerance.

[MiamiGent]

MiamiGent

Member Level
Re: None

Friday, September 09, 2022 3:32:12 PM

Post#
622407 of 622435

AMLX I just got in at 29.80
Received recommendation of FDA Independant Advisory Committee yesterday
Up 60+% between yesterday and today.
I'm counting on "the three day rule" and publicity over weekend to send it higher Monday
A drug for ALS where there is little to offer sufferers now
https://stockcharts.com/h-sc/ui?s=AMLX

[sorkin]

Bought $30 puts

[sorkin]

Sold my $30 calls

[subslover]

And the run continues :))))))))))))))))))))))0

[subslover]

Oh, ok. I think it's phenomenal. AMLX

[sorkin]

Will SRPT buy AMLX?

[sorkin]

Hope you are not right

[TheFinalCD]

your the man of many gif's


reminds me of someone

[Invest-in-America]

AMLX: Heck, as for myself, I just deploy my (Proprietary/Patented) 'TIME MACHINE' (See my original Patent Office vid., below); go back to the PREVIOUS trading day; buy a big CHUNK of the stock in question; then brag the following day as to how SMART I am!!

[Invest-in-America]

AMLX: Well, a classic SUCKERS-BAIT-MORNING-GAPPER today; but nonetheless, perhaps a Medical History 'HOME RUN' (pun intended) for the treatment of old "LOU GEHRIG's DISEASE". (Was this a WITTY post, or WHAT, Dudes??!!!)

[TheFinalCD]

they usually send me a text first

LOL

have a nice day

[subslover]

HOD was $35. Could head back that way without notice!

[TheFinalCD]

slow chop&grind form the gap up $35 on down

[subslover]

Wow!

[Pt3]

Please unhalted I need 1st entry

[TheFinalCD]

$AMLX 17.90 Amylyx Pharma wins FDA advisory committee backing for ALS drug

https://seekingalpha.com/news/3881055-amylyx-pharma-wins-fda-advisory-committee-backing-for-als-drug


https://investors.amylyx.com/news-releases/news-release-details/amylyx-pharmaceuticals-stock-trading-halted-today-0